Fractional AI for healthcare, built around HIPAA, not bolted on after.

You are a digital health founder with somewhere between twenty and fifty people on the team. You have raised a Series A. You have a clinical advisor on payroll, a security officer who is also somebody else, and a compliance backlog the size of a closet. Then you watch a competitor announce an AI feature and your CEO asks why you do not have one yet. So you start the obvious way. You look at Apollo for sales. You look at ChatGPT for content. You look at Intercom Fin for support. You start reading the terms. Within an afternoon you have eight tabs open, three different DPAs, two flavors of BAA language, and a sinking feeling that none of this clears your legal team without six weeks of review.

The reason is structural. Default AI tools were built for SaaS teams in clean verticals. The cloud endpoint sees your prospects, your transcripts, your tickets. That works fine if you are selling Calendly. It does not work the moment a single field could carry PHI. A patient name in a chat transcript is PHI. A symptom description in a support ticket is PHI. A provider note attached to a sales conversation is PHI. A telemedicine session transcript is PHI. The minute one of those touches a vendor that has not signed a BAA, that has not been audited under HIPAA Security Rule, that does not have a written breach-notification process, you have a reportable incident waiting to happen. So the path of least resistance is to skip AI entirely, which is what most healthcare teams between twenty and fifty employees end up doing. They stall on compliance review for six months. Their competitors do not.

The honest answer is that healthcare AI is not a tooling problem. It is a posture problem. The teams that ship are the ones who decided on day one which workloads can run on cloud and which cannot, who picked vendors with BAAs and audit trails for the cloud side, and who put on-device infrastructure under the PHI side. That decision tree exists before any agent goes live. Most teams do not have anybody on staff whose job is to build that decision tree. That is what a fractional AI consultancy is for, and that is the conversation our healthcare engagements start with.

The shape of a real healthcare AI stack is not pure cloud and not pure on-prem. It is hybrid by design, and the design follows the data classification. Marketing automation, B2B sales prospecting against provider organizations, blog content, landing pages, social, internal Slack copilots that read your wiki and not your EHR. All of that can live on cloud agents with the usual BAA-backed vendors. The audit trail is light, the latency is fast, the cost per task is low. The PHI surface is zero by definition because the workflow never sees a patient record.

The other half is different. Patient support, intake flows, triage messaging, anything that reads provider notes, anything that drafts clinical summaries, anything that touches an EHR or EMR, anything inside the patient portal. Those workloads run on a local agent inside your network or your private cloud region. The model never leaves the perimeter. The audit log captures every prompt, every retrieval, every output. The architecture lets you point at a single sentence in a compliance review and say the data never crossed a vendor boundary, because the agent was running on hardware you control.

The split sounds expensive. It is not. The cloud side carries ninety percent of the volume at a tenth of the cost. The on-device side handles the regulated minority on hardware that pays for itself in twelve months versus per-token cloud pricing at PHI volume. We have shipped this hybrid pattern for clients running everything from telemedicine triage to RCM SaaS, and the architecture is the same shape every time. We documented the on-device side in detail on the local agent setup page. The cloud side runs on the same fractional department playbook as every other industry, with one important difference: every workflow is built with a PHI-detection guard so the agent refuses to process a payload that should have been routed to local in the first place.

A general-purpose tech team with twenty engineers can absorb a single AI hire and have that person ramp on the codebase in a quarter. A healthcare team cannot. The new hire spends their first quarter learning your data classification policy, your BAA inventory, your access control model, your audit logging requirements, your clinical advisory board sign-off process. By the time they are productive on the actual AI work, you have burned six months and a hundred and fifty thousand dollars on a single hire who still does not know which of your workflows are inside the HIPAA boundary.

The fractional model collapses that ramp because the compliance posture is what we bring on day one. We have already shipped the hybrid pattern. We have the BAA templates, the PHI-detection guard logic, the clinician escalation patterns, the audit log retention defaults. Your security officer reviews our design against your specific controls and signs off on a known shape instead of waiting for a new hire to discover the same shape over six months. The monthly retainer is smaller than the loaded cost of one AI engineer hire, and the output is four departments running, not one engineer slowly learning the regulatory landscape.

The other reason fractional fits healthcare is volume variance. A digital health company will run a six-week marketing burst around a payer partnership announcement, then run quiet for two months while the clinical team validates a new flow. A patient support queue at a telemedicine company spikes in flu season and drops in summer. Per-hire economics punish that variance because you cannot fire the SDR in June and rehire them in October. Fractional economics absorb it. The retainer covers whatever volume the agents need to ship that month, inside the contractual cap.

The first thing that changes is meeting load. Healthcare teams without an AI compliance posture spend an enormous amount of executive time arguing about whether a given workflow can use AI. The CTO weighs in, the security officer weighs in, the clinical advisor weighs in, legal weighs in, and the conversation reaches no decision because nobody owns the architecture. Once the posture is documented and shipped, those meetings stop. The decision tree exists. Marketing knows their stack. Patient support knows their stack. The CTO does not get pulled into a thirty-minute argument about whether a chatbot can answer a billing question.

The second thing that changes is the speed of clinical adjacent work. Drafting patient-facing educational content used to take a six-week cycle: marketing writes, clinical reviews, compliance reviews, marketing rewrites, the cycle repeats. With the content department running inside the posture, the first draft comes in already aligned to your regulatory boundary, citing your approved sources, avoiding the disease-state language your counsel has flagged. The clinical review still happens. It happens once instead of three times, on copy that did not need a rewrite to begin with.

The third thing that changes is patient experience under load. The bottleneck on after-hours patient inquiries at most digital health companies is staffing economics. You cannot pay twelve people to sit on a queue that is mostly silent between midnight and six AM but has a real volume spike on Sunday nights when refill questions come in. The support agent absorbs that spike at flat retainer cost, answers the logistics questions, and escalates the clinical drift to the on-call clinician with the full conversation context already attached. Response time on after-hours triage drops from hours to seconds for the operational tier, and clinicians get woken up only when somebody actually needs to be woken up.

The fourth thing that changes is your runway. Every engineering quarter you do not spend rebuilding AI compliance from first principles is a quarter you ship product. Every clinician hour you do not burn on routine tier-one questions is an hour on a real patient case. The unit economics of a healthcare company between Series A and Series B are brutal, and the teams that survive past forty employees are the ones who got AI compliance out of the way early and let the rest of the org focus on the actual clinical mission.